1. |
Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. J Lancet, 2007, 369(9574): 1731-1741.
|
2. |
Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw, 2007, 5(Suppl 2): S1-29.
|
3. |
钱红纲, 郝纯毅. 胃肠间质瘤复发和转移的治疗. 中国实用外科杂志, 2010, (4): 281-285.
|
4. |
Schubert ML, Moghimi R. Gastrointestinal stromal tumor (GIST). Curr Treat Options Gastroenterol, 2006, 9(2): 181-188.
|
5. |
邓爱平, 王成林. 胃肠间质瘤X诊断(附5例分析). 罕少疾病杂志, 2007, 14(6): 8-10.
|
6. |
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 2008, 39(10): 1411-1419.
|
7. |
Cancer Therapy Evaluation Program. Common toxicity criteria manual:common toxicity criteria, version 3.0[G]. Behesda, Md: National Cancer Institute, April 10 2003.
|
8. |
Stamatakos M, Douzinas E, Stefanaki C, et al. Gastrointestinal stromal tumor. World J Surg Oncol, 2009, 7: 61.
|
9. |
Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18): 3813-3125.
|
10. |
DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for surviva1. Ann Surg, 2000, 23 1(1): 51-58.
|
11. |
D’Amato G, Steinert DM, McAulifie JC, et al. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control, 2005, 12(1): 44-56.
|
12. |
Heinrich MC, Griffith DJ, Druker BJ, et al. Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood, 2000, 96(3): 925-932.
|
13. |
Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med, 2001, 344(14): 1052-1056.
|
14. |
Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet, 2009, 373(9669): 1097-1104.
|
15. |
蔡成机. 胃肠间质瘤的诊治理念. 中国普通外科杂志, 2007, 16(9): 887-889.
|
16. |
龚军, 彭彬, 黄义明, 等. 胃肠间质瘤9例临床分析. 医师进修杂志, 2005, 28(11): 36-37.
|
17. |
龚勋, 陈宗佑, 项建斌. 胃肠间质瘤诊断与治疗进展. 国际外科学杂志, 2008, 35(3): 177-180.
|
18. |
黄权. 32例胃肠间质瘤的诊断与外科治疗. 广西医科大学学报, 2010, 27(4): 625-626.
|
19. |
Iwahashi M, Takifuji K, Ojima T, et al. Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg, 2006, 30(1): 28-35.
|
20. |
. 陆琪, 李蔚萍, 程爱群, 等. 胃肠问质瘤87例临床分析. 中国实用外科杂志, 2010, 30(4): 301-303.
|
21. |
. 詹文华, 王鹏志, 邵永孚, 等. 伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告. 中华胃肠外科杂志, 2006, 9(5): 383-387.
|